LUND, SWEDEN--(Marketwire - December 10, 2008) - Active Biotech AB (NASDAQ OMX Nordic: ACTI) has presented results related to the cancer project ANYARA where the effect of ANYARA was studied in combination with other established tumor therapies in experimental models of cancer.
